Search hospitals > West Virginia > Bridgeport

United Hospital Center

Claim this profile
Bridgeport, West Virginia 26330
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Recurrence
74 reported clinical trials
11 medical researchers
Photo of United Hospital Center in BridgeportPhoto of United Hospital Center in BridgeportPhoto of United Hospital Center in Bridgeport

Summary

United Hospital Center is a medical facility located in Bridgeport, West Virginia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Recurrence and other specialties. United Hospital Center is involved with conducting 74 clinical trials across 178 conditions. There are 11 research doctors associated with this hospital, such as Stephan R. Paul, Nour Daboul, Mohammed Almubarak, MD, and Lauren W. Veltri.

Area of expertise

1Cancer
Global Leader
United Hospital Center has run 29 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage III
2Breast Cancer
Global Leader
United Hospital Center has run 16 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
PR positive

Top PIs

Clinical Trials running at United Hospital Center

Non-Small Cell Lung Cancer
Lung Cancer
Gallbladder Cancer
Ovarian Tumors
Cancer
Rectal Cancer
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Anal Squamous Cell Carcinoma
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Genetic Testing

for Early-Stage Lung Cancer

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at United Hospital Center?
United Hospital Center is a medical facility located in Bridgeport, West Virginia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Recurrence and other specialties. United Hospital Center is involved with conducting 74 clinical trials across 178 conditions. There are 11 research doctors associated with this hospital, such as Stephan R. Paul, Nour Daboul, Mohammed Almubarak, MD, and Lauren W. Veltri.